Data from: On-demand sildenafil as a treatment for Raynaud phenomenon: a series of n-of-1 trials

Matthieu Roustit, Joris Giai, Olivier Gaget, Charles Khouri, Myriam Mouhib, Adrien Lotito, Sophie Blaise, Christophe Seinturier, Fabien Subtil, Adeline Paris, Claire Cracowski, Bernard Imbert, Patrick Carpentier, Sunita Vohra & Jean-Luc Cracowski
Background: Treatment of Raynaud phenomenon (RP) with phosphodiesterase-5 inhibitors has shown moderate efficacy. Adverse effects decrease the risk–benefit profile of these drugs, and patients may not be willing to receive long-term treatment. On-demand single doses before or during exposure to cold may be a good alternative. Objective: To assess the efficacy and safety of on-demand sildenafil in RP. Design: Series of randomized, double-blind, n-of-1 trials. (ClinicalTrials.gov: NCT02050360). Setting: Outpatients at a French university hospital. Participants:...

Registration Year

  • 2019
    1

Resource Types

  • Dataset
    1

Affiliations

  • Hospices Civils de Lyon
    1
  • University of Alberta
    1
  • Grenoble Alpes University
    1